Health Technology · Medical Specialties · NSE: POLYMED · data 2026-10-09
Poly Medicure Limited
Health check: Average (5.4/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,587.1
Market cap
₹16,231 cr
P/E
51.1
P/B
—
ROE
11.0%
ROCE
10.9%
Debt / equity
0.11
Dividend yield
0.22%
1-year return
-17.6%
52-week high
₹2,094.3
52-week low
₹1,182
Operating margin
16.7%
Growth
| Revenue (last 12 months) | ₹1,997 cr |
| Net profit (last 12 months) | ₹315 cr |
| Sales growth, 3 years (yearly) | 18.8% |
| Profit growth, 3 years (yearly) | 21.6% |
Chart patterns
- Double top — breakdown (key level ₹1,639)
- Descending triangle — breakdown (key level ₹1,681.7)
Similar companies
Lenskart Solutions Limited (LENSKART) · Molbio Diagnostics Limited (MOLBIO) · Standard Engineering Technology Ltd (SETL) · Virtuoso Optoelectronics Limited (VOEPL) · Q-Line Biotech Limited (QLINE)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open POLYMED in NSE Scanner →